p63 is an alternative p53 repressor in melanoma that confers chemoresistance and a poor prognosis.

J Exp Med · 2013 · PMC3600906 · PMID 23420876

Europe PMC DOI

hedged sentences

0.1050

closest p · 2.1× alpha

0.1050

boldest claim

The sentences

failed to reach significanceP = 0.105not close (p > 0.1)

Univariate and multivariate analysis demonstrated an upward trend toward increased metastatic rates in the p63-positive cohort but failed to reach significance (P = 0.105, Wald test; not depicted).

also in 4,113 other papers

a positive trendno p-value reported

Analysis of the p63-positive population demonstrated a significant association with Breslow thickness of primary melanoma and a positive trend toward shorter time to recurrence and to metastases.

also in 11,005 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.